Dynasty Wealth Management LLC Sells 165 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Dynasty Wealth Management LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.5% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 10,691 shares of the healthcare conglomerate’s stock after selling 165 shares during the quarter. Dynasty Wealth Management LLC’s holdings in UnitedHealth Group were worth $5,408,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Davis Rea LTD. lifted its position in shares of UnitedHealth Group by 31.2% during the fourth quarter. Davis Rea LTD. now owns 23,438 shares of the healthcare conglomerate’s stock valued at $11,856,000 after buying an additional 5,575 shares during the last quarter. First American Bank lifted its position in UnitedHealth Group by 2.9% during the fourth quarter. First American Bank now owns 42,634 shares of the healthcare conglomerate’s stock valued at $21,567,000 after acquiring an additional 1,187 shares during the last quarter. Parkside Financial Bank & Trust increased its position in shares of UnitedHealth Group by 1.8% during the fourth quarter. Parkside Financial Bank & Trust now owns 5,971 shares of the healthcare conglomerate’s stock worth $3,020,000 after purchasing an additional 107 shares in the last quarter. Hilltop Partners LLC boosted its position in shares of UnitedHealth Group by 26.7% in the 4th quarter. Hilltop Partners LLC now owns 3,891 shares of the healthcare conglomerate’s stock worth $1,968,000 after purchasing an additional 820 shares in the last quarter. Finally, Sentinel Trust Co. LBA increased its position in UnitedHealth Group by 4.6% during the 4th quarter. Sentinel Trust Co. LBA now owns 5,951 shares of the healthcare conglomerate’s stock valued at $3,010,000 after buying an additional 261 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently commented on UNH. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Oppenheimer boosted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a report on Friday, January 10th. Finally, Truist Financial dropped their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Trading Up 1.2 %

NYSE UNH opened at $469.11 on Friday. The firm’s fifty day moving average price is $517.10 and its 200 day moving average price is $557.79. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a market capitalization of $431.71 billion, a price-to-earnings ratio of 30.26, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the business earned $5.83 EPS. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.79%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.